Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 11-2015 | 08-2015 | 05-2015 | 02-2015 | 11-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,975 | 7,103 | 14,127 | 15,695 | 4,970 |
| Receivables | 50,283 | 44,654 | 46,479 | 46,521 | 52,454 |
| Inventories | 28,859 | 28,423 | 25,027 | 24,662 | 30,440 |
| Income taxes - deferred | 2,065 | 2,038 | 2,111 | 1,987 | 1,985 |
| TOTAL | $95,194 | $87,346 | $93,202 | $92,491 | $94,944 |
| Non-Current Assets | |||||
| PPE Net | 95,869 | 85,954 | 84,465 | 78,960 | 78,375 |
| Investments And Advances | 62,500 | 62,300 | 61,500 | 61,100 | 59,793 |
| Intangibles | 105,459 | 105,680 | 105,883 | 106,104 | 106,325 |
| Other Non-Current Assets | 2,083 | 1,305 | 1,415 | 1,648 | 1,662 |
| TOTAL | $265,911 | $255,239 | $253,263 | $247,812 | $246,155 |
| Total Assets | $361,105 | $342,585 | $346,465 | $340,303 | $341,099 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,527 | 7,650 | 8,353 | 16,891 | 12,550 |
| Accounts payable and accrued liabilities | 36,921 | 31,946 | 35,009 | 28,312 | 39,516 |
| Accrued Expenses | 5,383 | 3,913 | 6,742 | 4,744 | 4,973 |
| TOTAL | $62,615 | $49,318 | $56,159 | $55,840 | $62,189 |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,685 | 32,953 | 34,166 | 32,901 | 34,675 |
| Deferred Revenues | 381 | 854 | 843 | 1,102 | 211 |
| Other Non-Current Liabilities | 1,612 | 1,493 | 1,691 | 1,655 | 1,626 |
| TOTAL | $71,818 | $69,258 | $70,197 | $68,964 | $67,802 |
| Total Liabilities | $134,433 | $118,576 | $126,356 | $124,804 | $129,991 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,033 | 27,015 | N/A | 26,947 | 26,876 |
| Common Shares | 27 | 27 | 27 | 27 | 27 |
| Retained earnings | 89,918 | 88,050 | 85,098 | 80,902 | 77,130 |
| Other shareholders' equity | 1,525 | 1,713 | 1,677 | 1,622 | 1,591 |
| TOTAL | $226,672 | $224,009 | $220,109 | $215,499 | $211,108 |
| Total Liabilities And Equity | $361,105 | $342,585 | $346,465 | $340,303 | $341,099 |